Abstract

Gut microbial β-glucuronidase (GUS) enzymes play important roles in drug efficacy and toxicity, intestinal carcinogenesis, and mammalian-microbial symbiosis. Recently, the first catalog of human gut GUS proteins was provided for the Human Microbiome Project stool sample database and revealed 279 unique GUS enzymes organized into six categories based on active-site structural features. Because mice represent a model biomedical research organism, here we provide an analogous catalog of mouse intestinal microbial GUS proteins-a mouse gut GUSome. Using metagenome analysis guided by protein structure, we examined 2.5 million unique proteins from a comprehensive mouse gut metagenome created from several mouse strains, providers, housing conditions, and diets. We identified 444 unique GUS proteins and organized them into six categories based on active-site features, similarly to the human GUSome analysis. GUS enzymes were encoded by the major gut microbial phyla, including Firmicutes (60%) and Bacteroidetes (21%), and there were nearly 20% for which taxonomy could not be assigned. No differences in gut microbial gus gene composition were observed for mice based on sex. However, mice exhibited gus differences based on active-site features associated with provider, location, strain, and diet. Furthermore, diet yielded the largest differences in gus composition. Biochemical analysis of two low-fat-associated GUS enzymes revealed that they are variable with respect to their efficacy of processing both sulfated and nonsulfated heparan nonasaccharides containing terminal glucuronides.IMPORTANCE Mice are commonly employed as model organisms of mammalian disease; as such, our understanding of the compositions of their gut microbiomes is critical to appreciating how the mouse and human gastrointestinal tracts mirror one another. GUS enzymes, with importance in normal physiology and disease, are an attractive set of proteins to use for such analyses. Here we show that while the specific GUS enzymes differ at the sequence level, a core GUSome functionality appears conserved between mouse and human gastrointestinal bacteria. Mouse strain, provider, housing location, and diet exhibit distinct GUSomes and gus gene compositions, but sex seems not to affect the GUSome. These data provide a basis for understanding the gut microbial GUS enzymes present in commonly used laboratory mice. Further, they demonstrate the utility of metagenome analysis guided by protein structure to provide specific sets of functionally related proteins from whole-genome metagenome sequencing data.

Highlights

  • Gut microbial ␤-glucuronidase (GUS) enzymes play important roles in drug efficacy and toxicity, intestinal carcinogenesis, and mammalian-microbial symbiosis

  • The Human Microbiome Project (HMP) samples were collected from 139 healthy donors that gave rise to 4.8 million unique gene products; using structure-guided features specific to GUS enzymes, we identified 279 distinct GUS proteins in this HMP data set—an HMP GUSome

  • A high-quality mouse gut wholegenome metagenome data set was provided by Xiao et al in 2015 [17]. These data were collected from eight mouse strains that had been obtained from five providers housed in six locations worldwide and fed two distinct diets [17]. Using these data and metagenome analysis guided by protein structure, here we report the identification of 444 distinct GUS proteins from the 2.5 million unique proteins identified in the mouse gut metagenome data set

Read more

Summary

Introduction

Gut microbial ␤-glucuronidase (GUS) enzymes play important roles in drug efficacy and toxicity, intestinal carcinogenesis, and mammalian-microbial symbiosis. Provider, housing location, and diet exhibit distinct GUSomes and gus gene compositions, but sex seems not to affect the GUSome These data provide a basis for understanding the gut microbial GUS enzymes present in commonly used laboratory mice. The gut microbial ␤-glucuronidase (GUS) enzymes had been hypothesized to be responsible for the dose-limiting adverse outcomes caused by administration of the anticancer drug irinotecan as early as 1995 [9], and ␤-glucuronidase activity had been known to be present in mammalian feces since the early 1970s [10,11,12,13] Their role in irinotecan toxicity was established in 2010 and was controlled using microbial GUS-specific inhibitors that alleviated intestinal damage and diarrhea [7]. We categorized the HMP GUS proteins into six structural classes and demonstrated that they sampled different levels of activity with distinct glucuronic acid-containing substrates [15]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.